These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33708864)

  • 21. Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Do Not Predict Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Khabbaz RC; Lokken RP; Chen YF; Lipnik AJ; Bui JT; Ray CE; Gaba RC
    Cardiovasc Intervent Radiol; 2018 Jul; 41(7):1029-1034. PubMed ID: 29516241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
    Lu LH; Zhang YF; Mu-Yan C; Kan A; Zhong XP; Mei J; Ling YH; Li SH; Shi M; Wei W; Guo RP
    Dig Liver Dis; 2019 Oct; 51(10):1430-1437. PubMed ID: 31054962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
    Kudo M; Galle PR; Brandi G; Kang YK; Yen CJ; Finn RS; Llovet JM; Assenat E; Merle P; Chan SL; Palmer DH; Ikeda M; Yamashita T; Vogel A; Huang YH; Abada PB; Yoshikawa R; Shinozaki K; Wang C; Widau RC; Zhu AX
    JHEP Rep; 2021 Apr; 3(2):100215. PubMed ID: 33392490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Kim JH; Sinn DH; Lee JH; Hyun D; Cho SK; Shin SW; Chang Y; Kim YJ; Yoon JH; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Choi MS
    Dig Dis Sci; 2018 Apr; 63(4):1062-1071. PubMed ID: 29442276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
    Invest New Drugs; 2015 Dec; 33(6):1257-62. PubMed ID: 26462681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
    Luo HM; Zhao SZ; Li C; Chen LP
    Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Albumin-bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia.
    Man ZR; Gong XK; Qu KL; Pang Q; Wu BQ
    World J Gastrointest Oncol; 2024 May; 16(5):1763-1772. PubMed ID: 38764822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Baseline Albumin-Bilirubin Grade on Predict Overall Survival Among Sorafenib-Treated Patients With Hepatocellular Carcinoma in Vietnam.
    Nguyen TTH; Nguyen VH; Nguyen VH; Nguyen TL; Le VQ
    Cancer Control; 2019; 26(1):1073274819865269. PubMed ID: 31364390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib.
    Fidan E; Fidan S; Merev E; Kazaz N
    Niger J Clin Pract; 2022 Feb; 25(2):173-177. PubMed ID: 35170443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.
    Kuo YH; Wang JH; Hung CH; Rau KM; Wu IP; Chen CH; Kee KM; Hu TH; Lu SN
    J Gastroenterol Hepatol; 2017 Dec; 32(12):1975-1981. PubMed ID: 28295594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASARA, a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Jia KF; Wang H; Yu CL; Yin WL; Zhang XD; Wang F; Sun C; Shen W
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):490-497. PubMed ID: 35260337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Xu L; Wu J; Lu W; Yang C; Liu H
    Transplant Proc; 2019 Dec; 51(10):3338-3346. PubMed ID: 31732203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
    Ho SY; Liu PH; Hsu CY; Tseng HT; Huang YH; Su CW; Hou MC; Huo TI
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Significance of Platelet-Albumin-Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count.
    Pang Q; Liu S; Wang L; Pan H; Wang C; Zhou L; Lu Y; Liu H
    Cancer Manag Res; 2020; 12():12811-12822. PubMed ID: 33364830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
    Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma.
    Carling U; Røsok B; Line PD; Dorenberg EJ
    Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma.
    Elshaarawy O; Alkhatib A; Elhelbawy M; Gomaa A; Allam N; Alsebaey A; Rewisha E; Waked I
    World J Hepatol; 2019 Jun; 11(6):542-552. PubMed ID: 31293722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
    Pinato DJ; Sharma R; Allara E; Yen C; Arizumi T; Kubota K; Bettinger D; Jang JW; Smirne C; Kim YW; Kudo M; Howell J; Ramaswami R; Burlone ME; Guerra V; Thimme R; Ishizuka M; Stebbing J; Pirisi M; Carr BI
    J Hepatol; 2017 Feb; 66(2):338-346. PubMed ID: 27677714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.